GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Myomo Inc (AMEX:MYO) » Definitions » Net Cash per Share

Myomo (MYO) Net Cash per Share : $0.12 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Myomo Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Myomo's Net Cash per Share for the quarter that ended in Dec. 2023 was $0.12.

The historical rank and industry rank for Myomo's Net Cash per Share or its related term are showing as below:

MYO' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 2.56   Med: 3.74   Max: 41.75
Current: 31.92

During the past 8 years, the highest Price-to-Net-Cash Ratio of Myomo was 41.75. The lowest was 2.56. And the median was 3.74.

MYO's Price-to-Net-Cash is ranked worse than
85.63% of 341 companies
in the Medical Devices & Instruments industry
Industry Median: 7.11 vs MYO: 31.92

Myomo Net Cash per Share Historical Data

The historical data trend for Myomo's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myomo Net Cash per Share Chart

Myomo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial -0.54 1.98 1.58 0.20 0.12

Myomo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.25 0.21 0.19 0.12

Competitive Comparison of Myomo's Net Cash per Share

For the Medical Devices subindustry, Myomo's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Myomo's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Myomo's Price-to-Net-Cash falls into.



Myomo Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Myomo's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(8.866-5.592-0)/27.135
=0.12

Myomo's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(8.866-5.592-0)/27.135
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Myomo  (AMEX:MYO) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Myomo Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Myomo's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Myomo (MYO) Business Description

Traded in Other Exchanges
Address
137 Portland Street, 4th Floor, Boston, MA, USA, 02114
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
Executives
Thomas F Kirk director
Milton Mayo Morris director 2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Paul R Gudonis director, officer: Chief Executive Officer 9 HICKORY ROAD, MANCHESTER MA 01944
David A Henry officer: Chief Financial Officer
Harry Kovelman officer: Chief Medical Officer C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Yitzchak Jacobovitz director MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Micah Mitchell officer: Chief Commercial Officer C/O MYOMO, INC., ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA 02139
Crowley Thomas Aloysius Jr. director 19 ST CLAIR AV, SPRING LAKE NJ 07762
Cliff Conneighton officer: Chief Marketing Officer 53 DEPOT ROAD, HOLLS NH 03049
Jonathan Naft officer: VP, General Manager C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Brandon M Green officer: Chief Medical Officer C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Ralph A Goldwasser officer: Chief Financial Officer BNN CORP, 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140
Davie Mendelsohn officer: VP, Sales C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Steve Sanghi director 2355 W CHANDLER BLVD, CHANDLER AZ 85224-6199
Amy K. Knapp director 75 N. MOUNTAIN AVE, MONTCLAIR NJ 07042